| UC Berkeley BioExec Institute - Growing Value | |
|
United States - CA - Berkeley |
|
| Hosted by: | UC Berkeley Center for Executive Education |
| Venue: | UC Berkeley |
| Dates: | Dec 06, 2012 through Dec 07, 2012 |
|
Description |
|
| Licensing and partnering are an integral part of the Biopharmaceutical industry. The formerly distinct pharmaceutical and biotechnology industries are merging into one interdependent Biopharmaceutical Industry. Partnered products are the future of innovation leading to a significant increase in attempts to acquire and/or license innovation from others. Big pharmaceutical companies will control fewer and fewer of their new products from discovery through line extension or OTC. This Day explores the underlying economics of deals; the different strategies for measuring risk; and how decisions are made amidst uncertainty. Featured Topics: • Financial trends in and pressures on the biopharma industry • The deal market today and coming up • The Buy-Side: What gets Big Pharma excited about an NME, regardless of who currently owns it? • The Sell-Side: How to prepare an asset and a biotech company to get the best deal possible? • De-risking the commercial prospects of a molecule • How the molecule’s commercial value impacts the deal • Getting it in Writing: Making sure the contract reflects the business • Success after the deal closes: Effective alliance management and post-acquisition integration issues |
|
| Additional Information | |
| Event URL: | http://executive.berkeley.edu/programs/bioexec-institute |
| ISCB Member Discount: | None |
| Contact Person: | Chelsea Hewitt ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
